Thrombotic microangiopathy (TMA) in a patient treated with antiviral therapy for hepatitis C

BMJ Case Rep. 2014 Apr 4:2014:bcr2013203290. doi: 10.1136/bcr-2013-203290.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Antiviral Agents / adverse effects*
  • Antiviral Agents / therapeutic use
  • Female
  • Hepatitis C / drug therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Interferon-alpha / therapeutic use
  • Middle Aged
  • Protease Inhibitors / adverse effects
  • Protease Inhibitors / therapeutic use
  • Thrombotic Microangiopathies / chemically induced*

Substances

  • Antiviral Agents
  • Interferon-alpha
  • Protease Inhibitors